Literature DB >> 11039711

Humoral human xenoreactivity against isolated pig pancreatic islets.

T Kin1, Y Nakajima, Y Aomatsu, H Kanehiro, M Hisanaga, S Ko, T Ohyama, H Nakano.   

Abstract

It is widely believed that the hyperacute rejection of vascularized xenografts in the pig-to-human combination is triggered by the binding of human preformed natural antibodies (PNAbs) to the Galalpha.(1,3)Gal epitope in pig endothelium and the subsequent activation of complement. However, it remains poorly defined whether xenogeneic pig pancreatic islets are damaged by antibody and complement-mediated mechanisms. We examined the expression of Galalpha(1,3)Gal on isolated adult pig islets and the presence of PNAbs in normal human sera directed against islets, using immunofluorescence staining and confocal laser scanning microscopy. The pig islets were not stained with Galalpha(1,3)Gal-specific lectin GSIB4, however, the exocrine cells reacted strongly with GSIB4, indicating that the Galalpha(1,3)Gal epitope was highly expressed on exocrine cells, but not on islets. Human sera showed weak reactivity of IgM and IgG class PNAbs to the islets, but strong reactivity to the exocrine cells. Furthermore, we investigated the cytotoxic effect of human serum on pig islets using an in vitro model of pig-to-human islet transplantation. The incubation of pig islets with normal human sera for 45 min resulted in less than 10% specific lysis despite the binding of PNAbs, whereas exposure of porcine aortic endothelial cells to the same human sera caused 56% complement-mediated lysis, determined using a MTT cytotoxic assay. These results support the view that pig islets might not undergo early antibody and complement-mediated rejection in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039711     DOI: 10.1007/s005950070065

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function.

Authors:  P Thompson; I R Badell; M Lowe; J Cano; M Song; F Leopardi; J Avila; R Ruhil; E Strobert; G Korbutt; G Rayat; R Rajotte; N Iwakoshi; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2011-08-29       Impact factor: 8.086

Review 2.  Treatment of diabetes with encapsulated pig islets: an update on current developments.

Authors:  Hai-tao Zhu; Lu Lu; Xing-yu Liu; Liang Yu; Yi Lyu; Bo Wang
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

3.  Evaluation of novel decellularizing corneal stroma for cornea tissue engineering applications.

Authors:  Yi Shao; Yao Yu; Chong-Gang Pei; Qiong Zhou; Qiu-Ping Liu; Gang Tan; Jing-Ming Li; Gui-Ping Gao; Lu Yang
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

4.  A novel method in preparation of acellularporcine corneal stroma tissue for lamellar keratoplasty.

Authors:  Yi Shao; Jing Tang; Yueping Zhou; Yangluowa Qu; Hui He; Qiuping Liu; Gang Tan; Wei Li; Zuguo Liu
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

5.  Changes of the Structural and Biomechanical Properties of the Bovine Pericardium after the Removal of α-Gal Epitopes by Decellularization and α-Galactosidase Treatment.

Authors:  Jinhae Nam; Sun-Young Choi; Si-Chan Sung; Hong-Gook Lim; Seong-Sik Park; Soo-Hwan Kim; Yong Jin Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.